Literature DB >> 636958

The biochemistry of lymphocyte-derived mediators of immunological inflammation.

J C Houck, K B Hellman, C M Chang.   

Abstract

Evidence is presented to indicate that there exists in lymphoid tissue, as a result of transforming lymphocytes, a new lymphokine which is chemotactically specific for lymphocytes, called 'lymphotactin'. Lymphotactin has been purified to electrophoretic homogeneity; has a molecular weight of 10,500 D and an isoelectric point of 5.9. Its role in amplifying the immune defense system by recruitment of naive lymphocytes into propinquity with the challenging antigens is suggested. Purification of macrophage migration inhibitory factor from thymus extracts to electrophoretic homogeneity leads to a compound of molecular weight of 36,500 D and an IEP of 6.9. Chemically it contains sialic acid and o-methyl glucopyranoside as its only carbohydrates. Purified MIF activates the macrophage phagocytically. Skin reactive factor and lymph node permeability factor have been isolated and purified and are found to be inhibited by pepstatin and antihistamine and to have an isoelectric point of pH 4.2 and a molecular weight of 50,000--100,000 D. It is believed that this anionic permeability increasing agent actually arises from the lysosomes of macrophages and lymphoblasts (the normal small lymphocyte having essentially no lysosomal organelles). The mononuclear cell infiltration characteristic of crude SRF and LNPF may proceed from their being contaminated with lymphotactin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 636958     DOI: 10.1007/bf01972405

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  38 in total

1.  The effect of tuberculin on sensitized and normal leucocytes.

Authors:  J MARKS; D M JAMES
Journal:  J Hyg (Lond)       Date:  1953-09

2.  The specificity of cathepsin D.

Authors:  J B Ferguson; J R Andrews; I M Voynick; J S Fruton
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

3.  Lymph node permeability factor in the dinitrochlorobenzene skin hypersensitivity reaction in guinea-pigs.

Authors:  D A Willoughby; M N Walters; W G Spector
Journal:  Immunology       Date:  1965-06       Impact factor: 7.397

4.  Macrophage migration inhibitory factor in thymus.

Authors:  J C Houck; C M Chang; M Platt
Journal:  Proc Soc Exp Biol Med       Date:  1973-07

5.  Protease activity as a possible mechanism of migration inhibitory factor.

Authors:  K Havemann; M Horvat; C P Sodomann; S Bürger
Journal:  Eur J Immunol       Date:  1972-02       Impact factor: 5.532

6.  Contact sensitivity in the pig.

Authors:  D E McFarlin; B Balfour
Journal:  Immunology       Date:  1973-12       Impact factor: 7.397

7.  Separation of immunologically active fragments by membrane partition chromatography.

Authors:  E M Zipilivan; B G Hudson; W F Blatt
Journal:  Anal Biochem       Date:  1969-07       Impact factor: 3.365

8.  Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines.

Authors:  G A Granger; G E Moore; J G White; P Matzinger; J S Sundsmo; S Shupe; W P Kolb; J Kramer; P R Glade
Journal:  J Immunol       Date:  1970-06       Impact factor: 5.422

9.  Lysosomal hyaluronidase from rat liver. I. Preparation.

Authors:  N N Aronson; E A Davidson
Journal:  J Biol Chem       Date:  1967-02-10       Impact factor: 5.157

10.  Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF.

Authors:  H G Remold
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  2 in total

1.  A low molecular weight proinflammatory factor from rat spleen lymphocytes. Isolation and partial characterization.

Authors:  Suzelei de Castro França; Maria Madalena Correa; Ieda Regina dos Santos Schivo; João Garcia Leme; José Roberto Giglio
Journal:  Inflammation       Date:  2007-05-02       Impact factor: 4.092

2.  Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin.

Authors:  B J Averbook; R S Yamamoto; T R Ulich; E W Jeffes; I Masunaka; G A Granger
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.